Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Cash from Operations (2019 - 2026)

Viatris (VTRS) posted Cash from Operations of $381.8 million for Q2 2026, down 1.67% on a QoQ basis from $388.3 million in Q1 2026, and up 73.78% year-over-year from $219.7 million in Q2 2025.

Analysis

Viatris (VTRS) Cash from Operations (2019 - 2026) Analysis & Trends

Viatris has reported Cash from Operations for 8 years, with the latest figure at $381.8 million in Q2 2026.

  • On a quarterly basis, Cash from Operations rose 73.78% year-over-year to $381.8 million in Q2 2026; TTM through Jun 2026 was $2.3 billion, a 12.9% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 0.56% from the prior year.
  • Cash from Operations was $381.8 million for Q2 2026 at Viatris, down from $388.3 million in the prior quarter.
  • The five-year high for Cash from Operations was $1.1 billion in Q1 2022, with the low at $189.0 million in Q4 2022.
  • Average Cash from Operations over 5 years is $627.1 million, with a median of $591.6 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2023: Cash from Operations plunged 63.87% in 2022, then jumped 200.79% in 2023.
  • Over 5 years, Cash from Operations stood at $189.0 million in 2022, then surged by 200.79% to $568.5 million in 2023, then fell by 15.09% to $482.7 million in 2024, then jumped by 69.01% to $815.8 million in 2025, then plunged by 53.2% to $381.8 million in 2026.
  • The last three Cash from Operations figures came in at $381.8 million (Q2 2026), $388.3 million (Q1 2026), and $815.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 411.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 381.80 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn -9.79 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn -21.24 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 670.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 56.67 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -19.79 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 51.32 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 -584,999.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 381.80 Mn
Mar 31, 2026 388.30 Mn
Dec 31, 2025 815.80 Mn
Sep 30, 2025 744.90 Mn
Jun 30, 2025 219.70 Mn
Mar 31, 2025 535.50 Mn
Dec 31, 2024 482.70 Mn
Sep 30, 2024 826.50 Mn
Jun 30, 2024 379.10 Mn
Mar 31, 2024 614.60 Mn
Dec 31, 2023 568.50 Mn
Sep 30, 2023 835.20 Mn
Jun 30, 2023 525.10 Mn
Mar 31, 2023 971.20 Mn
Dec 31, 2022 189.00 Mn
Sep 30, 2022 869.00 Mn
Jun 30, 2022 802.50 Mn
Mar 31, 2022 1.14 Bn
Dec 31, 2021 523.10 Mn
Sep 30, 2021 1.09 Bn